{"id":25023,"date":"2026-10-07T08:40:12","date_gmt":"2026-10-07T08:40:12","guid":{"rendered":"https:\/\/www.drfz.de\/?p=25023"},"modified":"2026-10-07T11:00:41","modified_gmt":"2026-10-07T11:00:41","slug":"gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance","status":"publish","type":"post","link":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/","title":{"rendered":"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance"},"content":{"rendered":"\n

Prof. Dr. Gerhard Kr\u00f6nke, Director of the Department of Medicine for Rheumatology and Clinical Immunology at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin and Head of the Liaison Group at the German Rheumatology Research Center Berlin (DRFZ), was awarded the Novartis Prize for immunological research with therapeutic relevance at the annual meeting of the German Society for Immunology (DGfI), on September 15, 2026.<\/p>\n\n\n\n

The physician received the award for his groundbreaking work in translating basic immunological research into innovative therapies for autoimmune diseases, particularly systemic lupus erythematosus. Of significance is his pivotal role in the development and clinical application of CD19-targeted CAR-T cell therapies, as well as the use of bispecific antibodies. Both approaches aim to selectively eliminate misdirected B cells, thereby enabling a lasting immunological \u201creset\u201d that can lead to long-term, mostly treatment-free remission. In addition, the award recognizes his research into deciphering a new anti-inflammatory mechanism of action of glucocorticoids and its significance for the development of new drugs.<\/p>\n\n\n\n

\n
Press release by DGfI<\/a><\/div>\n<\/div>\n\n\n\n

Novartis Prize for Immunological Research with Therapeutic Relevance<\/strong><\/h3>\n\n\n\n

The DGfI, in collaboration with the Novartis Foundation for Therapeutic Research, awards the Novartis Prize for Immunological Research with Therapeutic Relevance annually. The prize, endowed with 10,000 euros, recognizes work that bridges the gap between immunological and clinical research. The prize money may be used exclusively for research purposes.<\/p>\n\n\n\n

\n
\n

News about publications by Gerhard Kr\u00f6nke<\/h2>\n \n \n
\n \n
\n
\n \n CAR-T Cell Therapy Shows Promise for Severe Rheumatoid Arthritis<\/a>\n\n \n \n <\/span>\n <\/a>\n <\/div>\n
\n \n New mechanism of cortisone action deciphered<\/a>\n\n \n \n <\/span>\n <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/section>\n\n\n\n\n
\n
\n \n
\n \n\n
\n \"\" <\/div>\n
\n

Prof. Dr. Gerhard Kr\u00f6nke<\/h2>\n
\n Liaison working group with Charit\u00e9 – Rheumatologie und Klinische Immunologie<\/p>\n <\/div>\n <\/div>\n\n
\n

gerhard.kroenke@charite.de<\/a><\/p>\n <\/div>\n Prof. Dr. Gerhard Kr\u00f6nke<\/span><\/a>\n<\/article> <\/div>\n <\/div>\n <\/section>\n\n\n\n

Photo: Novartis-Awardee Gerhard Kr\u00f6nke (l.) with DGfI-President Hansj\u00f6rg Schild (Mi.) and Laudator J\u00fcrgen Ruland (r.)<\/p>\n","protected":false},"excerpt":{"rendered":"

Prof. Dr. Gerhard Kr\u00f6nke, Director of the Department of Medicine for Rheumatology and Clinical Immunology at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin and Head of the Liaison\u2026<\/p>\n","protected":false},"author":4,"featured_media":25031,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[288,292],"tags":[442,489,497],"programme-area-tax":[182],"working-group-tax":[253],"class_list":["post-25023","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-for-patients","category-news-en","tag-clinical-rheumatology","tag-kroenke","tag-program-area-4","programme-area-tax-programme-area-4","working-group-tax-clinical-rheumatology"],"acf":[],"yoast_head":"\nGerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance - DRFZ<\/title>\n<meta name=\"description\" content=\"Gerhard Kr\u00f6nke from Charit\u00e9 and DRFZ awarded Novartis Prize for immunological research with therapeutic relevance by DGfI\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance - DRFZ\" \/>\n<meta property=\"og:description\" content=\"Gerhard Kr\u00f6nke from Charit\u00e9 and DRFZ awarded Novartis Prize for immunological research with therapeutic relevance by DGfI\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/\" \/>\n<meta property=\"og:site_name\" content=\"DRFZ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/drfz.de\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-07T08:40:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-07T11:00:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/10\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ute Hoffmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:site\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ute Hoffmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/\"},\"author\":{\"name\":\"Ute Hoffmann\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\"},\"headline\":\"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance\",\"datePublished\":\"2026-10-07T08:40:12+00:00\",\"dateModified\":\"2026-10-07T11:00:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/\"},\"wordCount\":248,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg\",\"keywords\":[\"Clinical Rheumatology\",\"Kr\u00f6nke\",\"Program area 4\"],\"articleSection\":[\"For patients\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/\",\"name\":\"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance - DRFZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg\",\"datePublished\":\"2026-10-07T08:40:12+00:00\",\"dateModified\":\"2026-10-07T11:00:41+00:00\",\"description\":\"Gerhard Kr\u00f6nke from Charit\u00e9 and DRFZ awarded Novartis Prize for immunological research with therapeutic relevance by DGfI\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Verleihung Preis Kr\u00f6nke Schild Ruland\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"name\":\"DRFZ\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\",\"name\":\"Deutsches Rheuma-Forschungszentrum\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Deutsches Rheuma-Forschungszentrum\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/drfz.de\\\/\",\"https:\\\/\\\/x.com\\\/DRFZ_Berlin\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/deutsches-rheuma-forschungszentrum-berlin\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCf8nDuqpkWwcmCWmfSTkE3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\",\"name\":\"Ute Hoffmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"caption\":\"Ute Hoffmann\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance - DRFZ","description":"Gerhard Kr\u00f6nke from Charit\u00e9 and DRFZ awarded Novartis Prize for immunological research with therapeutic relevance by DGfI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/","og_locale":"en_US","og_type":"article","og_title":"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance - DRFZ","og_description":"Gerhard Kr\u00f6nke from Charit\u00e9 and DRFZ awarded Novartis Prize for immunological research with therapeutic relevance by DGfI","og_url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/","og_site_name":"DRFZ","article_publisher":"https:\/\/www.facebook.com\/drfz.de\/","article_published_time":"2026-10-07T08:40:12+00:00","article_modified_time":"2026-10-07T11:00:41+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/10\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg","type":"image\/jpeg"}],"author":"Ute Hoffmann","twitter_card":"summary_large_image","twitter_creator":"@DRFZ_Berlin","twitter_site":"@DRFZ_Berlin","twitter_misc":{"Written by":"Ute Hoffmann","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/#article","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/"},"author":{"name":"Ute Hoffmann","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737"},"headline":"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance","datePublished":"2026-10-07T08:40:12+00:00","dateModified":"2026-10-07T11:00:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/"},"wordCount":248,"publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/10\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg","keywords":["Clinical Rheumatology","Kr\u00f6nke","Program area 4"],"articleSection":["For patients","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/","url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/","name":"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance - DRFZ","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/#primaryimage"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/10\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg","datePublished":"2026-10-07T08:40:12+00:00","dateModified":"2026-10-07T11:00:41+00:00","description":"Gerhard Kr\u00f6nke from Charit\u00e9 and DRFZ awarded Novartis Prize for immunological research with therapeutic relevance by DGfI","breadcrumb":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/#primaryimage","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/10\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/10\/26_10_07_Gerhard_Kroenke_Novartispreis_Beitragsbild.jpg","width":1280,"height":720,"caption":"Verleihung Preis Kr\u00f6nke Schild Ruland"},{"@type":"BreadcrumbList","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/gerhard-kroenke-awarded-novartis-prize-for-immunological-research-with-therapeutic-relevance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drfz.de\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.drfz.de\/en\/news\/"},{"@type":"ListItem","position":3,"name":"Gerhard Kr\u00f6nke awarded Novartis Prize for immunological research with therapeutic relevance"}]},{"@type":"WebSite","@id":"https:\/\/www.drfz.de\/en\/#website","url":"https:\/\/www.drfz.de\/en\/","name":"DRFZ","description":"","publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drfz.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.drfz.de\/en\/#organization","name":"Deutsches Rheuma-Forschungszentrum","url":"https:\/\/www.drfz.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","width":1,"height":1,"caption":"Deutsches Rheuma-Forschungszentrum"},"image":{"@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/drfz.de\/","https:\/\/x.com\/DRFZ_Berlin","https:\/\/www.linkedin.com\/company\/deutsches-rheuma-forschungszentrum-berlin","https:\/\/www.youtube.com\/channel\/UCf8nDuqpkWwcmCWmfSTkE3w"]},{"@type":"Person","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737","name":"Ute Hoffmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","caption":"Ute Hoffmann"}}]}},"_links":{"self":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/25023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/comments?post=25023"}],"version-history":[{"count":4,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/25023\/revisions"}],"predecessor-version":[{"id":25038,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/25023\/revisions\/25038"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media\/25031"}],"wp:attachment":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media?parent=25023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/categories?post=25023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/tags?post=25023"},{"taxonomy":"programme-area-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/programme-area-tax?post=25023"},{"taxonomy":"working-group-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/working-group-tax?post=25023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}